Last updated on July 2015

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-small-cell Lung Cancer
  • Age: Between 18 - 75 Years
  • Gender: Male or Female
  • Other:
    Histological or cytological confirmation of non-small-cell lung cancer (NSCLC).
    Diagnosis of non-systematic brain metastases on a Gadolinium-enhanced MRI. More than
    2 sites of intracranial metastases, or the longest diameter of the intracranial
    lesion is more than 3cm.
    No other metastases except for brain metastases.

You may not be eligible for this study if the following are true:

  • Previous usage of EGFR-TKI or antibody to EGFR: gefitinib, erlotinib, herceptin,
    erbitux.
    CSF or MRI findings consistent with metastases of spinal cord, meninges or meningeal.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.